Paying users zone. Data is covered by .
Get to Regeneron Pharmaceuticals Inc. for $13.99, or
get to whole website for at least 3 months from $49.99.
The income statement (statement of earnings) reports on the performance of Regeneron Pharmaceuticals Inc., the result of its operating activities.
The assets reports major classes and amounts of resources owned or controlled by Regeneron Pharmaceuticals Inc..
The liabilities and stockholders' equity reports major classes and amounts of external claims on assets and owners' capital contributions, and other internally generated sources of capital.
The cash flow statement provides information about Regeneron Pharmaceuticals Inc.'s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on Regeneron Pharmaceuticals Inc.'s statement of financial position.
Common-Size Financial Statements
Income statement components (revenues and expenses) shown as percentage of total sales.
Assets components shown as percentage of total assets.
Liabilities and stockholders' equity components shown as percentage of total liabilities and stockholders' equity.
Evaluates revenues and output generated by the Regeneron Pharmaceuticals Inc.'s assets. Operating performance ratios describe the relationship between the Regeneron Pharmaceuticals Inc.'s level of operations and the assets needed to sustain operating activities.
Measures how efficiently Regeneron Pharmaceuticals Inc. generates revenues from its investments in fixed or total assets.
Measures the adequacy of a Regeneron Pharmaceuticals Inc.'s cash resources to meet its near-term cash obligations.
Examines Regeneron Pharmaceuticals Inc.'s capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
Measures the income of Regeneron Pharmaceuticals Inc. relative to its revenues and invested capital.
An approach to decomposing Regeneron Pharmaceuticals Inc.'s return on equity as the product of other financial ratios.
Relative valuation technique determine the value of Regeneron Pharmaceuticals Inc. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock's value, such as earnings, book value, and sales.